GLRA1 and hereditary hyperekplexia: A point mutation at the murine Glra1 locus, which selectively suppresses Zn potentiation, generates a phenotype that mimics that of patients with hereditary startle disease and thus is indicative of decreased glycinergic inhibition (Betz and Laube 2006).